TSOI (TSOI) Stock Price & Analysis
TSOI (TSOI) rose 0.00% to USD 0 as of June 10, 2026 at 08:42 UTC, according to Nexqual real-time market data.
TSOI last closed at USD 0; the session ranged USD 0–0 on volume of 262,500 shares. Market capitalization is $512,270, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 08:42 UTC.
Key Statistics (as of June 10, 2026 at 08:42 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 262,500 shares |
| Market Cap | $512,270 |
| Exchange | PNK |
Technical Analysis (TSOI)
Nexqual's technical model rates TSOI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 08:42 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (TSOI)
Wall Street analysts rate TSOI "None", per Nexqual as of June 10, 2026 at 08:42 UTC.
| Consensus Rating | None |
|---|
Earnings (TSOI)
Source: Nexqual, June 10, 2026 at 08:42 UTC.
Financials & Fundamentals (TSOI)
| Total Revenue | $85,319 |
|---|---|
| Revenue Growth (YoY) | -23.60% |
| Gross Margin | +65.80% |
| Operating Margin | -9963.50% |
| Profit Margin | +0.00% |
| ROE | -250.40% |
| Debt / Equity | 55.28 |
| Current Ratio | 0.27 |
| Total Cash | $9,233 |
| Total Debt | $929,628 |
| Free Cash Flow | $317,209 |
Source: Nexqual, June 10, 2026 at 08:42 UTC.
Financial Health Score (TSOI)
Nexqual rates TSOI's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 08:42 UTC.
| Growth | Critical — Revenue -24% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $9K cash, no debt |
| Cash Flow | Strong — FCF $317K, 372% margin |
| Efficiency | Critical — ROE -250%, ROA -63.5% |
Ownership (TSOI)
| Insider Ownership | +15.04% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 5.12B |
| Float | 4.56B |
Source: Nexqual, June 10, 2026 at 08:42 UTC.
Leadership (TSOI)
TSOI is led by Timothy George Dixon (age 67), Chairman, CEO, President & CFO, per Nexqual as of June 10, 2026 at 08:42 UTC.
| Chairman, CEO, President & CFO | Timothy George Dixon (age 67) |
|---|---|
| Chief Scientific Officer | Feng Lin (age 54) |
| Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board | James Drew Veltmeyer (age 59) |
| Vice President of Business Development | Famela Ramos (age 48) |
| Director of Sales | Serena Robella |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CELZ | Creative Medical Technology Hol | USD 2.18 | ▲ 5.83% |
| HALB | Halberd Corp. | USD 0 | ▲ 10% |
| RGBP | Regen Biopharma, Inc. | USD 0 | ▼ 66.67% |
| TPTW | TPT Global Tech, Inc. | USD 0 | ▲ 0% |
| WDLF | Decentral Life, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:42 UTC. This page is informational and not investment advice.